ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Photodynamic therapy during second surgery for recurrent gliomas improves survival

Li, Yongning; Wang, Fang; Li, Bo*哈尔滨医科大学; 1
Photodiagnosis and Photodynamic Therapy2022-6DOI: 10.1016/j.pdpdt.2022.102754
5被引13阅读
引用收藏
分享

摘要

Background: Glioma accounts for most central nervous system tumors, and the degree of invasion and malignancy are higher in the recurrent glioma. Photodynamic therapy (PDT) is an effective strategy in glioma. This study aimed to explore the risk factors for re-recurrence after a second glioma surgery and the effects of PDT on re-recurrence. @@@ Methods: This was a retrospective study in the Second Affiliated Hospital of Harbin Medical University in China, and 43 patients that received the secondary surgery for recurrent glioma were included. The Kaplan-Meier test and Cox proportional hazard method were used to analyze. @@@ Results: The total re-recurrence rate after the second surgery for recurrent glioma was 48.84%. When the age increased by 1, the risk of re-recurrence increased 1.065 times (95% CI 1.000-1.134, P = 0.049). High matrix metalloproteinase (MMP) 2 expression was associated with a significantly higher risk of re-recurrence than low MMP2 expression (HR = 25.550, 95% CI 3.190-204.650, P = 0.002). Pathological grades IV and III were associated with a significantly higher risk of re-recurrence than pathological grade II (HR = 17.121, 95% CI 2.345-124.986, P = 0.005; HR = 2863.470, 95% CI 100.697-81,427.197, P < 0.001). PDT decreased the risk of re-recurrence (HR = 25.550, 95% CI 3.190-204.650, P = 0.002) and increased survival time (HR = 3.611, 95% CI 1.012-12.888, P = 0.048). @@@ Conclusion: The age, MMP2 expression, and pathological grade are independent risk factors for re-recurrence after a second surgery for recurrent glioma. PDT during the second surgery decreased the risk of re-recurrence and increased survival time.

学科与关键词

关键词
Re-recurrenceRisk factorRecurrent gliomaPhotodynamic therapy
相关
加载中…
  • Photodynamic therapy enhances the cytotoxicity of temozolomide against glioblastoma via reprogramming anaerobic glycolysis
    Li, Yongzhe; Wang, Dan; Zhang, Zhaoxia; Wang, Yunzhi; Zhang, Zichen; Liang, Zibin*; Liu, Fei*; Chen, Lei*Photodiagnosis and Photodynamic Therapy, 2023, 42: 103342.被引 1
  • Using mixed reality technique combines multimodal imaging signatures to adjuvant glioma photodynamic therapy
    Dong, Jiawei; Wang, Fang; Xu, Yuyun; Gao, Xin; Zhao, Hongtao; Zhang, Jiheng; Wang, Nan; Liu, Zhihui; Yan, Xiuwei; Jin, Jiaqi; Ji, Hang; Cheng, Ruiqi; Wang, Lihai; Qiu, Zhaowen*; Hu, Shaoshan*Frontiers in Medicine, 2023, 10: 1171819.
  • Clinical significance of histopathological features of paired recurrent gliomas: a cohort study from a single cancer center
    Li, Cong; Xi, Shaoyan; Chen, Yingshen; Guo, Chengcheng; Zhang, Ji; Yang, Qunying; Wang, Jian; Sai, Ke; Zeng, Jing; Wang, Jing; Zhang, Zhiqiang; Ke, Chao; Chen, Zhongping*BMC CANCER, 2023, 23(1).被引 1
查看全部 →

发表信息

论文状态
公开发表
期刊
Photodiagnosis and Photodynamic Therapy
发表日期
2022-06
卷期
第 38 卷
页码
102754
DOI
10.1016/j.pdpdt.2022.102754
语言
ENGLISH
期刊等级
3区
成果收录
SCIE
资助标注
Natural Science Research Project Foundation of Bengbu Medical College [BYKY1616]

作者

  • L

    Li, Yongning (第一作者)

    1 · da lian med univ

  • W

    Wang, Fang

    2 · harbin med univ

查看全部 3 位作者收起作者
  • L

    Li, Bo (通讯)

    wenzhou med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417